Taichu is a biotechnology enterprise distinguished by its core competitive advantage in "CRO+CDMO integrated services", specializing in providing end-to-end technical solutions for global innovative drug development spanning from early-stage discovery through preclinical research
We have received your business plan. After completing an initial evaluation, our investment team will contact projects that align with our investment focus. Due to the volume of submissions, we appreciate your understanding if you do not receive a follow-up. We wish your project every success!
OK
This website uses cookies
This website uses cookies to improve your experience while you navigate through the website. You
can choose to opt-out if you wish. For more information, please refer to our
《Cookies》。